Wordt geladen...
Monotherapy with Metformin versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis
BACKGROUND: Accumulating evidence suggests that patients with type 2 diabetes mellitus and hyperinsulinemia are at an increased risk of developing malignancies. It remains to be fully elucidated whether the use of metformin, an insulin sensitizer, and/or sulfonylureas, insulin secretagogues, affects...
Bewaard in:
| Gepubliceerd in: | J Diabetes Res |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6885827/ https://ncbi.nlm.nih.gov/pubmed/31828167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7676909 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|